Skin Blends – Young
August 3rd, 2013 4:43 am
Skin Blends - Young Rich StemTide Moisturizer, with Swiss Apple Stem Cells Messenger Peptides
By: SkinBlends101
Here is the original post:
Skin Blends - Young
Umbilical Cord Stem Cells: Regeneration, Repair, Inflammation and Autoimmunity – Neil Riordan PhD P1 – Video
August 1st, 2013 5:47 pm
Umbilical Cord Stem Cells: Regeneration, Repair, Inflammation and Autoimmunity - Neil Riordan PhD P1
(Part 1 of 2) Neil Riordan, PhD is the Founder of the Stem Cell Institute in Panama. He is also the Co-Founder of Medistem Inc in San Diego and the current P...
By: http://www.cellmedicine.com
Continued here:
Umbilical Cord Stem Cells: Regeneration, Repair, Inflammation and Autoimmunity - Neil Riordan PhD P1 - Video
Stem Cells Knee Quadriceps Disruption- Bodybuilding Champion-30 months post-op – Video
August 1st, 2013 5:47 pm
Stem Cells Knee Quadriceps Disruption- Bodybuilding Champion-30 months post-op
This over-50 National and North American bodybuilding champion had a spontaneous distal quadriceps disruption. He was treated by Dr Bennett of Sarasota, Flor...
By: William Bennett
Link:
Stem Cells Knee Quadriceps Disruption- Bodybuilding Champion-30 months post-op - Video
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments – Video
July 31st, 2013 7:42 pm
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments. Telecast on 23/6/2013 Stem Cell Therapy done at Dr Alok Sharma Ne...
By: Neurogen Brain and Spine Institute
Read this article:
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments - Video
Stem Cell Therapy for Knees – Video
July 31st, 2013 7:42 pm Read More...Stem Cell Therapy – Amazing Breakthrough in Skin wrinkles treatment – Video
July 31st, 2013 7:42 pm
Stem Cell Therapy - Amazing Breakthrough in Skin wrinkles treatment
Stem Cell Therapy is the newest bio-active topical cream that actually stimulates your own existing skin stem cells to grow smooth, supple, firm new skin. Fo...
By: Buystemcell.com.au
The rest is here:
Stem Cell Therapy - Amazing Breakthrough in Skin wrinkles treatment - Video
Discussing: My intro Stem Cell Therapy – Video
July 30th, 2013 1:43 pm
Discussing: My intro Stem Cell Therapy
This video explains my intro into the World of MS.
By: Tiffany Vinson
Here is the original post:
Discussing: My intro Stem Cell Therapy - Video
BrainStorm’s NurOwn Cell Therapy Receives Orphan Drug Designation in the European Union for ALS
July 30th, 2013 1:43 pmNEW YORK, NY and PETAH TIKVA, ISRAEL--(Marketwired - Jul 29, 2013) - BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the European Commission has granted Orphan Drug Designation for NurOwn, the Company's stem cell therapy consisting of autologous bone marrow-derived mesenchymal stromal cells secreting neurotrophic factors, for the treatment of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease.NurOwn received Orphan Drug Designation from the Food and Drug Administration (FDA) in 2011.
Orphan drugs benefit from 10 years market exclusivity in the European Union (EU) after marketing approval. Additional benefits for sponsor companies include reduced fees for various centralized activities including applications for marketing authorization, inspections and protocol assistance, as well as possible eligibility for EU grants and other R&D-supporting initiatives.
BrainStorm is currently conducting a Phase IIa dose-escalating trial with 12 ALS patients at the Hadassah Medical Center in Jerusalem, Israel. The company anticipates launching a Phase II multi-center trial at three leading institutions in the United States towards the end of 2013, pending FDA approval.
About BrainStorm Cell Therapeutics, Inc.BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University. For more information, visit the company's website at http://www.brainstorm-cell.com.
Safe Harbor Statement - Statements in this announcement other than historical data and information constitute "forward-looking statements" and involve risks and uncertainties that could cause BrainStorm Cell Therapeutics Inc.'s actual results to differ materially from those stated or implied by such forward-looking statements. Terms and phrases such as "may", "should", "would", "could", "will", "expect", "likely", "believe", "plan", "estimate", "predict", "potential", and similar terms and phrases are intended to identify these forward-looking statements.The potential risks and uncertainties include, without limitation, risks associated with BrainStorm's limited operating history, history of losses; minimal working capital, dependence on its license to Ramot's technology; ability to adequately protect the technology; dependence on key executives and on its scientific consultants; ability to obtain required regulatory approvals; and other factors detailed in BrainStorm's annual report on Form 10-K and quarterly reports on Form 10-Q available at http://www.sec.gov.These factors should be considered carefully, and readers should not place undue reliance on BrainStorm's forward-looking statements.The forward-looking statements contained in this press release are based on the beliefs, expectations and opinions of management as of the date of this press release. We do not assume any obligation to update forward-looking statements to reflect actual results or assumptions if circumstances or management's beliefs, expectations or opinions should change, unless otherwise required by law. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.
Original post:
BrainStorm's NurOwn Cell Therapy Receives Orphan Drug Designation in the European Union for ALS
How calcium effects adult neural stem cells – Dr Michael Weible – Video
July 30th, 2013 12:49 pm
How calcium effects adult neural stem cells - Dr Michael Weible
By: Eskitis Institute
Read the original post:
How calcium effects adult neural stem cells - Dr Michael Weible - Video
Quadriceps Disruption-Stem Cells-National Over 50 Bodybuilding Champion 2008 – Video
July 30th, 2013 12:49 pm
Quadriceps Disruption-Stem Cells-National Over 50 Bodybuilding Champion 2008
Bob, a 54 year old bodybuilder who 2 years before won the National Over-50 bodybuilding championship and one year earlier won the over- 50 North American cha...
By: William Bennett
See original here:
Quadriceps Disruption-Stem Cells-National Over 50 Bodybuilding Champion 2008 - Video
TheArcadiumCast plays Binding of Isaac – Flying With Stem Cells and Googly Eyes – Video
July 30th, 2013 12:49 pm
TheArcadiumCast plays Binding of Isaac - Flying With Stem Cells and Googly Eyes
Binding of Isaac, a Zelda-esque top-down challenging game, is what Tyler is playing today on TheArcadiumCast. He goes through things like chests where Isaa...
By: TheArcadiumCast
Read more here:
TheArcadiumCast plays Binding of Isaac - Flying With Stem Cells and Googly Eyes - Video
Part 2 Stem Cell Therapy – Video
July 30th, 2013 12:47 pm Read More...Child Receives Implanted Trachea Created From Her Own Stem Cells – Video
July 29th, 2013 10:45 am
Child Receives Implanted Trachea Created From Her Own Stem Cells
http://www.arthritistreatmentcenter.com A child receives an implanted trachea which was created from her own stem cells. The implanted stem cell for a trache...
By: Nathan Wei
Read the original:
Child Receives Implanted Trachea Created From Her Own Stem Cells - Video
Curing osteoarthritis with stem cells – Video
July 29th, 2013 10:45 am
Curing osteoarthritis with stem cells
http://www.stemcellsarthritistreatment.com My story begins in 1981 when I finished my training at the National Institutes of Health. I had no idea what I wan...
By: Nathan Wei
Fat transfer to face with stem cells. Enhanze Clinic – Video
July 29th, 2013 10:45 am
Fat transfer to face with stem cells. Enhanze Clinic
By: enhanzeclinic
Read more:
Fat transfer to face with stem cells. Enhanze Clinic - Video
Mac Stem Cell Therapy 2012 – Video
July 29th, 2013 10:43 am
Mac Stem Cell Therapy 2012
Before and After Mac #39;s Stem Cell Therapy. Surgery done by Dr. Mark McCloskey, DVM, Columbus, OH.
By: Mary Hammond
Read the rest here:
Mac Stem Cell Therapy 2012 - Video
California Stem Cell Official Duane Roth in Improving Condition
July 28th, 2013 3:05 amDuane Roth, the co-vice chairman of the
California stem cell agency, is improving after he was hospitalized
for treatment of a serious brain injury sustained in a bicycle accident Sunday in
the mountains east of San Diego.
California stem cell agency, is improving after he was hospitalized
for treatment of a serious brain injury sustained in a bicycle accident Sunday in
the mountains east of San Diego.
According to a report on Xconomy.com,
Roth's brother, Ted, said yesterday,
Roth's brother, Ted, said yesterday,
“Were certainly moving in the
right direction. We're now looking at the recovery phase.”
The article by Bruce Bigelow said Roth
has passed through the most critical period following surgery at the
UC San Diego hospital.
has passed through the most critical period following surgery at the
UC San Diego hospital.
Roth, the 63-year-old CEO of the San
Diego technology organization, Connect, is in serious condition in a
medically induced coma.
Diego technology organization, Connect, is in serious condition in a
medically induced coma.
The governing board of the California
stem cell agency yesterday took special note of Roth at its meeting and sent its best wishes to him and his family.
stem cell agency yesterday took special note of Roth at its meeting and sent its best wishes to him and his family.
Source:Another $23 Million to Recruit Star Stem Cell Scientists to California
July 28th, 2013 3:05 amCalifornia's $46 million effort to lure
stem cell research stars to the Golden State was expanded today by
another $23 million.
stem cell research stars to the Golden State was expanded today by
another $23 million.
Directors of the stem cell agency
approved the funds on a 14-4-1 vote. CIRM directors Jeff Sheehy and
Francisco Prieto were among those opposing the move. Prieto declared,
approved the funds on a 14-4-1 vote. CIRM directors Jeff Sheehy and
Francisco Prieto were among those opposing the move. Prieto declared,
“We are coming up against finite resources. We have better ways to spend
our money."
Sheehy said that CIRM is contributing to inflation in stem cell science with its lucrative recruitment grants.
Those supporting the expansion said that the grants have had a great impact on the field, not only bringing in individual scientists, but accompanying researchers in their labs along with grants from other sources.
The additional funds will go to
institutions that have not already benefited from one of the earlier
grants in the program. Up to four awards are expected to be made.
institutions that have not already benefited from one of the earlier
grants in the program. Up to four awards are expected to be made.
The CIRM staff proposal on the plan
said,
said,
“A number of California institutions
have not yet been able to secure a confirmed Research Leadership
award but would benefit greatly from the recruitment of emerging or
established leaders in stem cell biology. Participation in the CIRM
program could bring additional, exceptional researchers to
California, strengthen and synergize with other efforts to build up
local sustained research communities in stem cell biology and
medicine and provide ongoing leadership at the cutting edge of
California regenerative medicine.”
All of the California institutions
involved with the winning researchers have representatives on the
governing board of the stem cell agency. They are not allowed, however, to vote
on grants to their institutions or researchers -- only on proposals such as today's $23 expansion.
involved with the winning researchers have representatives on the
governing board of the stem cell agency. They are not allowed, however, to vote
on grants to their institutions or researchers -- only on proposals such as today's $23 expansion.
Applications are due in January with
final approval scheduled for next May. The program is not open to
businesses.
final approval scheduled for next May. The program is not open to
businesses.
Source:California Stem Cell Agency Launches $70 Million Alpha Stem Cell Clinic Project
July 28th, 2013 3:05 am
The California stem cell agency today approved
a $70 million plan to create a network of “Alpha” stem cell
clinics that is aimed at making the Golden State one of the leading
purveyors and developers of stem cell therapies in the world.
The 29-member governing board of the California
Institute for Regenerative Medicine (CIRM)adopted the plan on a 19-1 vote. The negative vote came from Joan Samuelson, who questioned
whether the plan was premature and whether existing scientific research justified development of the clinics.
Institute for Regenerative Medicine (CIRM)adopted the plan on a 19-1 vote. The negative vote came from Joan Samuelson, who questioned
whether the plan was premature and whether existing scientific research justified development of the clinics.
Sherry Lansing, a patient advocate board member and
former head of a Hollywood studio, said the proposal is “one of the
most exciting proposals that we have ever had in front of us.” She
said it was the “beginning of this dream coming true.”
former head of a Hollywood studio, said the proposal is “one of the
most exciting proposals that we have ever had in front of us.” She
said it was the “beginning of this dream coming true.”
Under the far-reaching proposal, which
CIRM President Alan Trounson has been promoting for two years, the
agency will finance five stem cell clinics at established
institutions in California with grants of up to $11 million. Another
$15 million will be allotted for a stem cell information and
coordination center. Major matching contributions will be expected
from award winners over the five-year terms of the grants.
CIRM President Alan Trounson has been promoting for two years, the
agency will finance five stem cell clinics at established
institutions in California with grants of up to $11 million. Another
$15 million will be allotted for a stem cell information and
coordination center. Major matching contributions will be expected
from award winners over the five-year terms of the grants.
The effort is aimed at drawing in
clinical trials and patients from the around the world and creating a
central bank of knowledge, know-how and regulatory expertise. It
will also guide efforts to build profits into stem cell therapies
and to develop strategies to attract investors and philanthropists.
(For more information on the plan, see here, here, here, here and
here.)
clinical trials and patients from the around the world and creating a
central bank of knowledge, know-how and regulatory expertise. It
will also guide efforts to build profits into stem cell therapies
and to develop strategies to attract investors and philanthropists.
(For more information on the plan, see here, here, here, here and
here.)
Trounson said in a statement,
“These clinics have the potential to
revolutionize how we deliver stem cell therapies to patients. Stem
cell therapies are a completely new way of treating diseases and
disorders so we need a completely new way of delivering those in a
safe and effective manner. These clinics will help us do just that
and the clinical trials carried out in this network will fulfill the
agency’s promise of bringing new therapies to patients who need
them.”
The journal Nature Medicine has
reported that the Alpha clinics would be the first-ever “clinical
trials network focused around a broad therapeutic platform.”
reported that the Alpha clinics would be the first-ever “clinical
trials network focused around a broad therapeutic platform.”
The CIRM board heard no negative
comment on the plan other than the remarks by Samuelson. . However,
not everyone sees a need for it. Mahendra Rao, director of the Center
for Regenerative Medicine at the National Institutes of
Health(NIH) , says its surveys of researchers have not shown a demand
for such centers. In May, a researcher at institution that likely
would be an applicant filed a blistering, anonymous comment on the
California Stem Cell Report, describing it as a "boondoggle" and "irresponsible." The scientist said,
comment on the plan other than the remarks by Samuelson. . However,
not everyone sees a need for it. Mahendra Rao, director of the Center
for Regenerative Medicine at the National Institutes of
Health(NIH) , says its surveys of researchers have not shown a demand
for such centers. In May, a researcher at institution that likely
would be an applicant filed a blistering, anonymous comment on the
California Stem Cell Report, describing it as a "boondoggle" and "irresponsible." The scientist said,
“Another boondoggle for some medical
schools but made to order for private operators like for-profit
cancer, dialysis, and laser eye specialty clinics that do one
procedure. I can see each of the medical schools gifted with
one as they each were gifted with about 25 million dollars for stem
cell institute buildings.”
The researcher continued,
“The NIH at various times has tried
to organize clinical trials groups with infrastructure, like quick
reaction forces, ready to gear up for a new trial at the drop of a
hat. They mainly did nothing but suck money, kept staff employed,
because there are generally few drugs ready for early human trials
and each treatment that is brought along requires a unique contract,
ethics reviews, and different facilities, equipment and staff than
planned for. The latest incarnation are CTSAs or CTSIs,
clinical and translational science centers funded by the federal NIH
that most if not all California medical schools already have.”
The RFA for the proposal is expected to
go out in October and approval of funding coming one year from now. Here is the link to today's CIRM press release on the plan.
go out in October and approval of funding coming one year from now. Here is the link to today's CIRM press release on the plan.
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/EBbBzLL9dQQ/california-stem-cell-launches-70.html
Coming Up: Live Coverage of Today’s California Stem Cell Meeting
July 28th, 2013 3:05 amThe California Stem Cell Report will
provide live, wall-to-wall coverage of today's meeting of the
governing board of the $3 billion California stem cell agency.
provide live, wall-to-wall coverage of today's meeting of the
governing board of the $3 billion California stem cell agency.
At the top of the agenda is a $70
million proposal aimed at creating a string of Alpha stem cell clinics in
California that would serve as a foundation for the state's stem cell
business. Also on tap are other proposed grant programs, including a
$23 million expansion of a researcher recruitment effort and a $35 million round aimed at removing roadblocks to turning research into
cures.
million proposal aimed at creating a string of Alpha stem cell clinics in
California that would serve as a foundation for the state's stem cell
business. Also on tap are other proposed grant programs, including a
$23 million expansion of a researcher recruitment effort and a $35 million round aimed at removing roadblocks to turning research into
cures.
Stories will be filed as warranted
throughout the day based on the Internet audiocast of the proceedings.
throughout the day based on the Internet audiocast of the proceedings.
Interested parties can also listen in
on the meeting via the Internet. Instructions can be found on the agenda.
on the meeting via the Internet. Instructions can be found on the agenda.
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/Vi8IGlL2TzY/coming-up-live-coverage-of-todays.html